Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
Status:
Completed
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to see whether the combination of trametinib and sorafenib
can help people with hepatocellular cancer. Researchers also want to find out if the
combination of trametinib and sorafenib is safe and tolerable.
Phase:
Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute